(*) USA Approval Date: 2019. 10.11
(*) USA Launch Date: 2020. 01.31.
>5-HT1F Agonist Tablets
Company
Generic Name: lasmiditan
HT: HydroxyTryptamine
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 10.26.
RTM
RTM Web-Site